Generic drugs are essential in oncology because some anticancer drugs are only available as generics.
The global Oncology Generic Injectable Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Oncology Generic Injectable Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oncology Generic Injectable Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Oncology Generic Injectable Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oncology Generic Injectable Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oncology Generic Injectable Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Oncology Generic Injectable Drugs sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
AstraZeneca
Roche
Eli Lilly
GlaxoSmithKline
Novartis
Mylan
Natco Pharma
Segment by Type
Large Molecule Drugs
Small Molecule Drugs
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Oncology Generic Injectable Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Oncology Generic Injectable Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Generic Injectable Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Oncology Generic Injectable Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Generic Injectable Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Large Molecule Drugs
1.2.3 Small Molecule Drugs
1.3 Market by Application
1.3.1 Global Oncology Generic Injectable Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oncology Generic Injectable Drugs Sales Estimates and Forecasts 2019-2030
2.2 Global Oncology Generic Injectable Drugs Revenue by Region
2.2.1 Global Oncology Generic Injectable Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Oncology Generic Injectable Drugs Revenue by Region (2019-2024)
2.2.3 Global Oncology Generic Injectable Drugs Revenue by Region (2025-2030)
2.2.4 Global Oncology Generic Injectable Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Oncology Generic Injectable Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Oncology Generic Injectable Drugs Sales by Region
2.4.1 Global Oncology Generic Injectable Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Oncology Generic Injectable Drugs Sales by Region (2019-2024)
2.4.3 Global Oncology Generic Injectable Drugs Sales by Region (2025-2030)
2.4.4 Global Oncology Generic Injectable Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Oncology Generic Injectable Drugs Sales by Manufacturers
3.1.1 Global Oncology Generic Injectable Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Oncology Generic Injectable Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oncology Generic Injectable Drugs in 2023
3.2 Global Oncology Generic Injectable Drugs Revenue by Manufacturers
3.2.1 Global Oncology Generic Injectable Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Oncology Generic Injectable Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Oncology Generic Injectable Drugs Revenue in 2023
3.3 Global Key Players of Oncology Generic Injectable Drugs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Oncology Generic Injectable Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oncology Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oncology Generic Injectable Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oncology Generic Injectable Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Oncology Generic Injectable Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oncology Generic Injectable Drugs Sales by Type
4.1.1 Global Oncology Generic Injectable Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Oncology Generic Injectable Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Oncology Generic Injectable Drugs Sales Market Share by Type (2019-2030)
4.2 Global Oncology Generic Injectable Drugs Revenue by Type
4.2.1 Global Oncology Generic Injectable Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Oncology Generic Injectable Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Oncology Generic Injectable Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Oncology Generic Injectable Drugs Price by Type
4.3.1 Global Oncology Generic Injectable Drugs Price by Type (2019-2024)
4.3.2 Global Oncology Generic Injectable Drugs Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Oncology Generic Injectable Drugs Sales by Application
5.1.1 Global Oncology Generic Injectable Drugs Historical Sales by Application (2019-2024)
5.1.2 Global Oncology Generic Injectable Drugs Forecasted Sales by Application (2025-2030)
5.1.3 Global Oncology Generic Injectable Drugs Sales Market Share by Application (2019-2030)
5.2 Global Oncology Generic Injectable Drugs Revenue by Application
5.2.1 Global Oncology Generic Injectable Drugs Historical Revenue by Application (2019-2024)
5.2.2 Global Oncology Generic Injectable Drugs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Oncology Generic Injectable Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Oncology Generic Injectable Drugs Price by Application
5.3.1 Global Oncology Generic Injectable Drugs Price by Application (2019-2024)
5.3.2 Global Oncology Generic Injectable Drugs Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Oncology Generic Injectable Drugs Market Size by Type
6.1.1 US & Canada Oncology Generic Injectable Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Oncology Generic Injectable Drugs Revenue by Type (2019-2030)
6.2 US & Canada Oncology Generic Injectable Drugs Market Size by Application
6.2.1 US & Canada Oncology Generic Injectable Drugs Sales by Application (2019-2030)
6.2.2 US & Canada Oncology Generic Injectable Drugs Revenue by Application (2019-2030)
6.3 US & Canada Oncology Generic Injectable Drugs Market Size by Country
6.3.1 US & Canada Oncology Generic Injectable Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Oncology Generic Injectable Drugs Sales by Country (2019-2030)
6.3.3 US & Canada Oncology Generic Injectable Drugs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Oncology Generic Injectable Drugs Market Size by Type
7.1.1 Europe Oncology Generic Injectable Drugs Sales by Type (2019-2030)
7.1.2 Europe Oncology Generic Injectable Drugs Revenue by Type (2019-2030)
7.2 Europe Oncology Generic Injectable Drugs Market Size by Application
7.2.1 Europe Oncology Generic Injectable Drugs Sales by Application (2019-2030)
7.2.2 Europe Oncology Generic Injectable Drugs Revenue by Application (2019-2030)
7.3 Europe Oncology Generic Injectable Drugs Market Size by Country
7.3.1 Europe Oncology Generic Injectable Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Oncology Generic Injectable Drugs Sales by Country (2019-2030)
7.3.3 Europe Oncology Generic Injectable Drugs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Oncology Generic Injectable Drugs Market Size
8.1.1 China Oncology Generic Injectable Drugs Sales (2019-2030)
8.1.2 China Oncology Generic Injectable Drugs Revenue (2019-2030)
8.2 China Oncology Generic Injectable Drugs Market Size by Application
8.2.1 China Oncology Generic Injectable Drugs Sales by Application (2019-2030)
8.2.2 China Oncology Generic Injectable Drugs Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Oncology Generic Injectable Drugs Market Size by Type
9.1.1 Asia Oncology Generic Injectable Drugs Sales by Type (2019-2030)
9.1.2 Asia Oncology Generic Injectable Drugs Revenue by Type (2019-2030)
9.2 Asia Oncology Generic Injectable Drugs Market Size by Application
9.2.1 Asia Oncology Generic Injectable Drugs Sales by Application (2019-2030)
9.2.2 Asia Oncology Generic Injectable Drugs Revenue by Application (2019-2030)
9.3 Asia Oncology Generic Injectable Drugs Sales by Region
9.3.1 Asia Oncology Generic Injectable Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Oncology Generic Injectable Drugs Revenue by Region (2019-2030)
9.3.3 Asia Oncology Generic Injectable Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oncology Generic Injectable Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Oncology Generic Injectable Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Oncology Generic Injectable Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Oncology Generic Injectable Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Oncology Generic Injectable Drugs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Oncology Generic Injectable Drugs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Oncology Generic Injectable Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Oncology Generic Injectable Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Oncology Generic Injectable Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Oncology Generic Injectable Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Information
11.1.2 Teva Pharmaceutical Overview
11.1.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Teva Pharmaceutical Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Pharmaceutical Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Pfizer Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 AstraZeneca Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Overview
11.4.3 Roche Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Roche Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Eli Lilly Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 GlaxoSmithKline Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Recent Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Overview
11.7.3 Novartis Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Novartis Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Overview
11.8.3 Mylan Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Mylan Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
11.9 Natco Pharma
11.9.1 Natco Pharma Company Information
11.9.2 Natco Pharma Overview
11.9.3 Natco Pharma Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Natco Pharma Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Natco Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oncology Generic Injectable Drugs Industry Chain Analysis
12.2 Oncology Generic Injectable Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oncology Generic Injectable Drugs Production Mode & Process
12.4 Oncology Generic Injectable Drugs Sales and Marketing
12.4.1 Oncology Generic Injectable Drugs Sales Channels
12.4.2 Oncology Generic Injectable Drugs Distributors
12.5 Oncology Generic Injectable Drugs Customers
13 Market Dynamics
13.1 Oncology Generic Injectable Drugs Industry Trends
13.2 Oncology Generic Injectable Drugs Market Drivers
13.3 Oncology Generic Injectable Drugs Market Challenges
13.4 Oncology Generic Injectable Drugs Market Restraints
14 Key Findings in The Global Oncology Generic Injectable Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Teva Pharmaceutical
Pfizer
AstraZeneca
Roche
Eli Lilly
GlaxoSmithKline
Novartis
Mylan
Natco Pharma
听
听
*If Applicable.